|
🐜
|
A global scientific strategy to cure hepatitis B.
51 auth.
P. Revill,
F. Chisari,
Joan M. Block,
M. Dandri,
A. Gehring,
Haitao Guo,
Jianming Hu,
A. Kramvis,
P. Lampertico,
H. Janssen,
M. Levrero,
Wenhui Li,
T. Liang,
S. Lim,
F. Lu,
...
M. Penicaud,
J. Tavis,
R. Thimme,
F. Zoulim,
P. Arbuthnot,
A. Boonstra,
K.‐M. Chang,
Per-Jei Chen,
D. Glebe,
L. Guidotti,
J. Fellay,
C. Ferrari,
L. Jansen,
Daryl T. Y. Lau,
Anna S.F. Lok,
M. Maini,
W. Mason,
G. Matthews,
D. Paraskevis,
J. Petersen,
B. Rehermann,
E. Shin,
A. Thompson,
F. van Bömmel,
Fu-sheng Wang,
Koichi Watashi,
Hung‐Chih Yang,
Zhenghong Yuan,
Man-Fung Yuen,
Tim Block,
V. Miller,
U. Protzer,
C. Bréchot,
S. Locarnini,
M. Peters,
R. Schinazi
|
8 |
2019 |
8
🐜
|
|
🐜
|
Sexual transmission of hepatitis C virus among monogamous heterosexual couples: The HCV partners study
12 auth.
N. Terrault,
J. Dodge,
E. Murphy,
E. Murphy,
J. Tavis,
A. Kiss,
...
T. Levin,
R. Gish,
M. Busch,
M. Busch,
A. Reingold,
M. Alter
|
8 |
2013 |
8
🐜
|
|
🐜
|
Multiple effects of silymarin on the hepatitis C virus lifecycle
17 auth.
J. Wagoner,
Amina A. Negash,
Olivia J. Kane,
Laura E. Martínez,
Y. Nahmias,
N. Bourne,
D. Owen,
J. Grove,
Claire L. Brimacombe,
J. McKeating,
...
E. Pécheur,
T. Graf,
N. Oberlies,
V. Lohmann,
F. Cao,
J. Tavis,
S. Polyak
|
7 |
2010 |
7
🐜
|
|
🐬
|
Hepatitis B virus nucleocapsid envelopment does not occur without genomic DNA synthesis
Tudevdagwa Gerelsaikhan,
J. Tavis,
V. Bruss
|
7 |
1996 |
7
🐬
|
|
🦁
|
Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer
J. Tavis,
Silvia Perri,
Don Ganem
|
7 |
1994 |
7
🦁
|
|
🐜
|
Immune evasion versus recovery after acute hepatitis C virus infection from a shared source
8 auth.
Ian A. Tester,
S. Smyk-Pearson,
Ping Wang,
A. Wertheimer,
E. Yao,
D. Lewinsohn,
...
J. Tavis,
H. Rosen
|
7 |
2005 |
7
🐜
|
|
🐜
|
Changes in Gene Expression during Pegylated Interferon and Ribavirin Therapy of Chronic Hepatitis C Virus Distinguish Responders from Nonresponders to Antiviral Therapy
12 auth.
Milton W. Taylor,
Takuma Tsukahara,
L. Brodsky,
J. Schaley,
Corneliu Sanda,
Matthew J. Stephens,
...
J. McClintick,
H. Edenberg,
Lang Li,
J. Tavis,
C. Howell,
S. Belle
|
7 |
2007 |
7
🐜
|
|
🐜
|
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.
17 auth.
E. Dazert,
C. Neumann-Haefelin,
S. Bressanelli,
K. Fitzmaurice,
J. Kort,
J. Timm,
S. McKiernan,
D. Kelleher,
N. Gruener,
J. Tavis,
...
H. Rosen,
J. Shaw,
P. Bowness,
H. Blum,
P. Klenerman,
R. Bartenschlager,
R. Thimme
|
7 |
2009 |
7
🐜
|
|
🐢
|
Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy
10 auth.
M. Donlin,
N. Cannon,
E. Yao,
Jia Li,
A. Wahed,
Milton W. Taylor,
...
S. Belle,
A. D. Di Bisceglie,
R. Aurora,
J. Tavis
|
6 |
2007 |
6
🐢
|
|
🐬
|
Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses
Yu Wei,
J. Tavis,
Don Ganem
|
6 |
1996 |
6
🐬
|
|
🦁
|
The Hepatitis B Virus Ribonuclease H Is Sensitive to Inhibitors of the Human Immunodeficiency Virus Ribonuclease H and Integrase Enzymes
11 auth.
J. Tavis,
Xiaohong Cheng,
Yuan Hu,
Michael Totten,
F. Cao,
E. Michailidis,
...
R. Aurora,
M. Meyers,
E. Jacobsen,
M. Parniak,
S. Sarafianos
|
6 |
2013 |
6
🦁
|
